Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-04-000465
Filing Date
2004-02-18
Accepted
2004-02-18 14:19:23
Documents
1
Group Members
ORBIMED ADVISORS LLCORBIMED CAPITAL LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 sc13ga_021604.txt SC 13G/A 10836
  Complete submission text file 0000947871-04-000465.txt   12607
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Subject) CIK: 0000890465 (see all company filings)

EIN.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-44877 | Film No.: 04612785
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 787 THIRD AVE NEW YORK NY 10010 2127396400
ISALY SAMUEL D (Filed by) CIK: 0001055949 (see all company filings)